The DNAJA2 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human A-549 lung adenocarcinoma cell line. These polyclonal cells feature a disrupted DNAJA2 gene, resulting in loss of functional DNAJA2 protein expression. This knockout model enables investigation of DNAJA2-dependent cellular processes in a lung epithelial context. The polyclonal nature preserves the heterogeneous genetic background of the parental population, offering a robust tool for studying gene function without the limitations of clonal selection.
The A-549 host cell line was established from human lung adenocarcinoma tissue and displays an adherent epithelial morphology. These cells serve as an alveolar basal epithelial model widely used to study lung adenocarcinoma biology, respiratory epithelium function, and cancer cell stress responses. The A-549 background provides a clinically relevant context for examining tumor cell proteostasis and therapeutic vulnerabilities, as lung adenocarcinoma is a prevalent malignancy with limited targeted treatment options.
DNAJA2 encodes a J-domain co-chaperone that stimulates the ATPase activity of Hsp70, thereby regulating protein folding, translocation, and degradation. It functions downstream of stress activation through HSF1 and interacts directly with Hsp70, Hsp90, and the E3 ubiquitin ligase CHIP (STUB1). Within the protein folding chaperone network, DNAJA2 participates in the heat shock response, ER-associated degradation (ERAD), and the unfolded protein response (UPR). By enhancing Hsp70 ATP hydrolysis, DNAJA2 facilitates the binding and release of client proteins, including nascent polypeptides and misfolded conformers, directing them toward productive folding or proteasomal clearance. Disruption of DNAJA2 disrupts this triage, potentially leading to accumulation of aggregated proteins and altered stress signaling.
In the A-549 lung adenocarcinoma model, loss of DNAJA2 is anticipated to compromise proteostasis capacity, rendering cells more susceptible to proteotoxic stress. Given the reliance of cancer cells on enhanced chaperone networks to survive oncogenic stress, DNAJA2 knockout may sensitize A-549 cells to heat shock, oxidative stress, or proteasome inhibition. This model thus provides a platform to dissect the role of Hsp70 co-chaperones in tumor cell stress adaptation and to evaluate the therapeutic potential of targeting proteostasis regulators in lung cancer.
Researchers can employ this knockout cell population in a range of experimental assays, including western blotting and RT-qPCR to confirm DNAJA2 ablation and Hsp70 expression, protein aggregation assays to assess proteostasis, cell viability assays under stress conditions, co-immunoprecipitation of Hsp70 complexes, proteasome activity measurements, and transcriptomic profiling via RNA-seq. These applications support studies on protein quality control in lung cancer, elucidation of Hsp70 co-chaperone functions, cancer cell stress biology, and validation of drug targets for proteostasis modulators. For inquiries or technical support, please contact Ascent Research.
